Among them, the FKBP5 is reported to be overexpressed in the primary tumors of brain cancer, prostate cancer, lymphoma, head and neck cancer, colorectal cancer, and downregulated in pancreatic cancer [37, 38, 39]. Here, FKBP5 is linked to Familial prostate cancer.